EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies

Anna Vera de Jonge iD, Tamás Csikós, Merve Eken, Elianne P Bulthuis, Pino J Poddighe, Margaretha G M Roemer, Martine E D Chamuleau iD, Tuna Mutis

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Vera de Jonge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Amsterdam UMC Location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In B-cell malignancies, the overexpression of MYC is associated with poor prognosis, but its mechanism underlying resistance to immunochemotherapy remains less clear. In further investigations of this issue, we show here that the pharmacological inhibition of MYC in various lymphoma and multiple myeloma cell lines, as well as patient-derived primary tumor cells, enhances their susceptibility to NK cell-mediated cytotoxicity induced by conventional antibodies targeting CD20 (rituximab) and CD38 (daratumumab), as well as T cell-mediated cytotoxicity induced by the CD19-targeting bispecific T-cell engager blinatumomab. This was associated with upregulation of the target antigen only for rituximab, suggesting additional escape mechanisms. To investigate these mechanisms, we targeted the MYC gene in OCI-LY18 cells using CRISPR-Cas9 gene-editing technology. CRISPR-Cas9-mediated MYC targeting not only upregulated CD20 but also triggered broader apoptotic pathways, upregulating pro-apoptotic PUMA and downregulating anti-apoptotic proteins BCL-2, XIAP, survivin and MCL-1, thereby rendering tumor cells more prone to apoptosis, a key tumor-lysis mechanism employed by T-cells and NK-cells. Moreover, MYC downregulation boosted T-cell activation and cytokine release in response to blinatumomab, revealing a MYC-mediated T-cell suppression mechanism. In conclusion, MYC overexpressing tumor cells mitigated the efficacy of therapeutic antibodies through several non-overlapping mechanisms. Given the challenges associated with direct MYC inhibition due to toxicity, successful modulation of MYC-mediated immune evasion mechanisms may improve the outcome of immunotherapeutic approaches in B-cell malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesHumansCell Line, TumorProto-Oncogene Proteins c-mycKiller Cells, NaturalAntibodies, BispecificApoptosisRituximabMultiple MyelomaCRISPR-Cas SystemsTumor EscapeAntigens, CD20Antibodies, Monoclonal

Stichwörter der Autor:innen

B-cell malignanciesCRISPR-Cas9MYCMYC inhibitionT cell-redirecting antibodiesantibody therapyimmunotherapylymphoma

Substanzen

Proto-Oncogene Proteins c-mycAntibodies, BispecificRituximabblinatumomabMYC protein, humanAntigens, CD20Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Hematology, Amsterdam UMC Location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Cancer Biology and Immunology, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Department of Clinical Human Genetics, Amsterdam UMC Location Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Anna Vera de Jonge, Martine E D Chamuleau

Zitieren

APA

de Jonge, A. V., Csikós, T., Eken, M., Bulthuis, E. P., Poddighe, P. J., Roemer, M. G. M., Chamuleau, M. E. D., & Mutis, T. (2024). Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212094

Vancouver

de Jonge AV, Csikós T, Eken M, Bulthuis EP, Poddighe PJ, Roemer MGM, et al. Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212094

BibTeX
@article{deJonge2024,
  author = {de Jonge, Anna Vera and Csikós, Tamás and Eken, Merve and Bulthuis, Elianne P and Poddighe, Pino J and Roemer, Margaretha G M and Chamuleau, Martine E D and Mutis, Tuna},
  title = {Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212094}
}
Kostenlos starten →